Cover Image
市場調查報告書

連續式血糖監測(CGM):技術及全球市場

Continuous Glucose Monitoring (CGM): Technologies and Global Markets

出版商 BCC Research 商品編碼 245912
出版日期 內容資訊 英文 98 Pages
訂單完成後即時交付
價格
Back to Top
連續式血糖監測(CGM):技術及全球市場 Continuous Glucose Monitoring (CGM): Technologies and Global Markets
出版日期: 2014年11月21日 內容資訊: 英文 98 Pages
簡介

全球連續式血糖監測儀(CGM)市場總額在2013年為2億7,940萬美金。該市場額預測從2014年到2019年這段期間將以年複合成長率19.6%的速度擴大,到2014年將達到3億2,090萬美元,2019年將達到7億8,390萬美元的規模。

本報告提供全球連續式血糖監測(CGM)市場相關的總括性調查,彙整包含世界市場趨勢,技術開發·各地區趨勢·市場動態·引進趨勢等重要的課題分析,各用途領域的市場明細,年齡·人種·各地區的資訊,及主要企業簡介等,為您概述為以下內容。

第1章 簡介

第2章 摘要

第3章 糖尿病的詳細分析

  • 胰臟的作用
  • 糖尿病的診斷
  • 糖尿病的類型
  • 全世界的肥胖及糖尿病的增加
  • 糖尿病的得病率和發生率
  • 血糖監測系統技術的歷史·現狀
  • 連續式血糖監測(CGM)系統的醫療保險·醫療費給付

第4章 產業結構

  • 胰島素幫浦提供企業
  • 血糖試紙的自我監測提供企業

第5章 主要市場

  • 連續式血糖監測(CGM)市場
  • 血糖儀表的自我監測·試紙市場
  • 價格·價格實際成果趨勢
  • 其他需求影響因素
  • 開業醫生·醫院用途的連續式血糖監測(CGM)

第6章 技術創新·開發平台·專利評估

  • 劃時代的大發現

第7章 主要臨床實驗

  • NICE-SUGAR實驗
  • MEDTRONIC的IN-CLINIC可行性研究,以觀察OVERNIGHT封閉迴路系統
  • 兒童及第一型糖尿病患者的自動封閉迴路型
  • 利用連續式血糖監測(CGM)的ICU的葡萄糖調節
  • 新的置入式連續式血糖監測器準確度的展望,多中心評估

第8章 企業簡介

  • ABBOTT DIABETES CARE INC.
  • ANIMAS CORP.
  • ARKRAY INC.
  • BAYER HEALTHCARE AG
  • BECTON, DICKINSON AND COMPANY
  • BRAUN MELSUNGEN AG
  • CEQUR SA
  • DEBIOTECH SA
  • DEXCOM INC.
  • EDWARDS LIFESCIENCES
  • GLYSENS INC.
  • INSULET CORP.
  • JOHNSON & JOHNSON
  • LABSTYLE INNOVATIONS CORP.
  • MEDTRONIC INC. MEDTRONIC DIABETES
  • MENARINI GROUP
  • ROCHE DIAGNOSTICS CORP.
  • SANOFI U.S.
  • SENSEONICS
  • TANDEM DIABETES CARE
  • VALERITAS

第9章 附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: HLC102B

The global market for continuous glucose monitoring products totaled $279.4 million in 2013. This market reached $320.9 million in 2014 and is expected to reach $783.9 million in 2019, registering a compound annual growth (CAGR) of 19.6% from 2014-2019.

This report provides:

  • An overview of the global market for continuos glucose monitoring (CGM).
  • Analyses of global market trends, with data from 2013 and 2014, and projections of compound annual growth rates (CAGRs) through 2019.
  • Examination of the critical issues of the CGM market including technological developments, geographic trends, market dynamics and adoption trends
  • Market breakdowns by application area: hospitals, diagnostics/clinics, home
  • Information broken down by age: children, teens, young, middle, elderly; by race: non-Hispanic whites, Hispanics, Asian Americans, Europeans, Asians, others; and by geography: the U.S., Europe, Asia, and the rest of the world
  • Receive information on leading companies including their product portfolios and recent developments.

image1

REPORT SCOPE

SCOPE OF REPORT

The scope of this study entails the current and forecast markets for glucose monitoring. The covered segments are continuous glucose monitoring transmitters and receivers, sensors, insulin pumps used in CGM, self-monitoring blood glucose (SMBG) equipment and test strips. The report also includes discussions of the reimbursement and regulatory environments, current and developing technologies, diabetes incidence, market projections and market share, as well as the latest trends and clinical trials.

ANALYST'S CREDENTIALS

Valerie Kellogg is an experienced medical device and pharmaceutical professional with international market research experience. She has authored numerous reports on topics ranging from the treatment of obesity to ablation devices, from wound care to the treatment of chronic migraine. Her strong focus areas include oncology, treatment of chronic disease, the latest in surgical devices and analysis of potential acquisitions.

Table of Contents

CHAPTER 1 INTRODUCTION

  • STUDY GOALS AND OBJECTIVES
  • REASONS FOR DOING THE STUDY
  • SCOPE OF REPORT
  • INTENDED AUDIENCE
  • INFORMATION SOURCES
  • ANALYST'S CREDENTIALS
  • RELATED BCC RESEARCH REPORTS
  • BCC RESEARCH WEBSITE
  • DISCLAIMER

CHAPTER 2 SUMMARY

  • SUMMARY TABLE 1 CONTINUOUS GLUCOSE MONITORING PRODUCT MARKET, THROUGH 2019 ($ MILLIONS)
  • SUMMARY FIGURE 1 GLOBAL CONTINUOUS GLUCOSE MONITOR PRODUCT MARKET, 2013-2019 ($ MILLIONS)
  • SUMMARY TABLE 2 BLOOD GLUCOSE METER AND DIABETES TEST STRIP MARKETS, THROUGH 2019 ($ MILLIONS)
  • SUMMARY FIGURE 2 GLOBAL BLOOD GLUCOSE METER AND DIABETES TEST STRIP MARKETS, 2013-2019 ($ MILLIONS)

CHAPTER 3 IN-DEPTH FOCUS ON DIABETES

  • ROLE OF THE PANCREAS
  • DIABETES DIAGNOSIS
  • DIABETES MELLITUS TYPES
    • TYPE 1
    • TYPE 2
    • GESTATIONAL DIABETES MELLITUS
  • GLOBAL OBESITY AND THE RISE OF DIABETES
    • TREATMENT
    • RACE FOR THE ARTIFICIAL PANCREAS
      • Animas, Juvenile Diabetes Research Foundation and the Hypoglycemia-Hyperglycemia Minimizer System
      • Predictive Low-Glucose-Suspend
      • Promise and Limitations of Pancreatic Islet Transplantation
  • PREVALENCE AND INCIDENCE OF DIABETES
    • COMPARATIVE ANALYSIS BY REGION
    • TABLE 1 GLOBAL AND REGIONAL DIABETES PREVALENCE, 2013 AND 2035 (MILLIONS)
    • TABLE 2 TOP 10 COUNTRIES WITH RESPECT TO DIABETIC POPULATIONS, 2013 AND 2035 (MILLIONS)
    • DIABETES MORTALITY AND ECONOMIC BURDEN
  • HISTORY AND CURRENT STATE OF BLOOD GLUCOSE MONITORING TECHNOLOGY
    • SELF-MONITORING BLOOD GLUCOSE DEVICES
      • Issues Concerning Blood Glucose Monitoring
      • Blood Glucose Meter Standards
      • Technology
      • Disposables
      • TABLE 3 INTERNATIONAL BLOOD LANCET SUPPLIERS
      • Electrochemical Blood Glucose Test Strips
    • CHALLENGES IN ACCURATELY MEASURING INTERSTITIAL GLUCOSE LEVELS
      • Continuous Glucose Monitoring Use in Children with Type 1 Diabetes
      • Improvements in Continuous Glucose Monitoring Technology
      • Smart Continuous Glucose Monitoring
      • GlySens Inc. and the GlySens Monitor
      • Dexcom's New Continuous Glucose Monitoring Device
      • Permanently Implanted Continuous Glucose Monitoring
      • TABLE 4 AVAILABLE FEATURES WITHIN CONTINUOUS GLUCOSE MONITORING SYSTEMS, SEPTEMBER 2014
    • GOVERNMENT REGULATIONS
      • American Association of Clinical Endocrinologists
      • American College of Endocrinology and American Association of Clinical Endocrinologists
    • U.S. FOOD AND DRUG ADMINISTRATION
    • JUVENILE DIABETES RESEARCH FOUNDATION AND THE ARTIFICIAL PANCREAS PROJECT RESEARCH
    • FIGURE 1 JUVENILE DIABETES RESEARCH FOUNDATION ARTIFICIAL PANCREAS PROJECT PLAN
  • HEALTHCARE INSURANCE AND REIMBURSEMENT FOR CONTINUOUS GLUCOSE MONITORING SYSTEMS
    • U.S.
    • CANADA
    • EUROPE
    • ASIA

CHAPTER 4 INDUSTRY STRUCTURE

  • TABLE 5 COMPANIES IN THE TRANSMITTER AND RECEIVER MARKET, 2014 ($ MILLIONS, %)
  • FIGURE 2 COMPANIES IN THE TRANSMITTER AND RECEIVER MARKET, 2014 (%)
  • TABLE 6 COMPANIES IN THE GLUCOSE SENSORS USED IN CONTINUOUS GLUCOSE MONITORING MARKET, 2014 ($ MILLIONS, %)
  • FIGURE 3 COMPANIES IN THE GLUCOSE SENSOR MARKET, 2014 (%)
  • TABLE 7 COMPANIES IN THE INSULIN PUMPS USED IN CONTINUOUS GLUCOSE MONITORING MARKET, 2014 ($ MILLIONS, %)
  • FIGURE 4 COMPANIES IN THE INSULIN PUMPS USED IN CONTINUOUS GLUCOSE MONITORING MARKET, 2014 (%)
  • COMPANIES SUPPLYING INSULIN PUMPS
    • ANIMAS CORP.
    • INSULET
    • MEDTRONIC MINIMED
    • ROCHE INSULIN DELIVERY SYSTEMS
    • SOOIL DEVELOPMENT CO.
    • TANDEM DIABETES CARE
    • TABLE 8 COMPANIES IN THE SELF-MONITORING OF BLOOD GLUCOSE METER MARKET, 2014 ($ MILLIONS, %)
    • FIGURE 5 COMPANIES IN THE SELF-MONITORING OF BLOOD GLUCOSE METER MARKET, 2014
  • COMPANIES OFFERING SELF-MONITORING OF BLOOD GLUCOSE TEST STRIPS
  • TABLE 9 COMPANIES IN THE SELF-MONITORING OF BLOOD GLUCOSE TEST STRIP MARKET, 2014 ($ MILLIONS, %)
  • FIGURE 6 COMPANIES IN SELF-MONITORING OF BLOOD GLUCOSE TEST STRIP MARKET, 2014

CHAPTER 5 MAJOR MARKETS

  • CONTINUOUS GLUCOSE MONITORING MARKETS
  • TABLE 10 GLOBAL CONTINUOUS GLUCOSE MONITORING PRODUCT MARKET SUMMARY, THROUGH 2019 ($ MILLIONS)
  • FIGURE 7 CONTINUOUS GLUCOSE MONITORING PRODUCT MARKETS, 2013-2019 ($ MILLIONS)
  • FIGURE 8 CONTINUOUS GLUCOSE MONITORING PRODUCT MARKETS BY REGION, 2013-2019 ($ MILLIONS)
  • TABLE 11 U.S. CONTINUOUS GLUCOSE MONITORING AND RELATED PRODUCT MARKET, THROUGH 2019 ($ MILLIONS)
  • TABLE 12 CANADA CONTINUOUS GLUCOSE MONITORING PRODUCT MARKET, THROUGH 2019 ($ MILLIONS)
  • TABLE 13 EU CONTINUOUS GLUCOSE MONITORING PRODUCT MARKET, THROUGH 2019 ($ MILLIONS)
  • TABLE 14 ASIA CONTINUOUS GLUCOSE MONITORING PRODUCT MARKET, THROUGH 2019 ($ MILLIONS)
  • TABLE 15 REST OF WORLD CONTINUOUS GLUCOSE MONITORING PRODUCT MARKET, THROUGH 2019 ($ MILLIONS)
  • TABLE 16 GLOBAL TRANSMITTER AND RECEIVER MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
  • TABLE 17 GLOBAL GLUCOSE SENSOR MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
  • TABLE 18 GLOBAL INSULIN PUMP MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
  • SELF-MONITORING OF BLOOD GLUCOSE METER AND TEST STRIP MARKETS
  • TABLE 19 GLOBAL SELF-MONITORING OF BLOOD GLUCOSE METER AND TEST STRIP MARKET SUMMARY, THROUGH 2019 ($ MILLIONS)
  • FIGURE 9 GLOBAL SELF-MONITORING OF BLOOD GLUCOSE METER AND TEST STRIP MARKET, 2013-2019
  • TABLE 20 GLOBAL SELF-MONITORING OF BLOOD GLUCOSE METER AND TEST STRIP MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
  • FIGURE 10 GLOBAL SELF-MONITORING OF BLOOD GLUCOSE METER AND TEST STRIP MARKET BY REGION, 2013-2019 ($ MILLIONS)
  • TABLE 21 GLOBAL SELF-MONITORING OF BLOOD GLUCOSE METER MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
  • TABLE 22 GLOBAL TEST STRIP MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
  • TABLE 23 U.S. SELF-MONITORING OF BLOOD GLUCOSE METER AND TEST STRIP MARKET, THROUGH 2019 ($ MILLIONS)
  • TABLE 24 CANADA SELF-MONITORING OF BLOOD GLUCOSE METER AND TEST STRIP MARKET, THROUGH 2019 ($ MILLIONS)
  • TABLE 25 E.U. SELF-MONITORING OF BLOOD GLUCOSE METER AND TEST STRIP MARKET, THROUGH 2019 ($ MILLIONS)
  • TABLE 26 ASIA SELF-MONITORING OF BLOOD GLUCOSE METER AND TEST STRIP MARKET, THROUGH 2019 ($ MILLIONS)
  • TABLE 27 REST OF WORLD SELF-MONITORING OF BLOOD GLUCOSE METER AND TEST STRIP MARKET, THROUGH 2019 ($ MILLIONS)
  • PRICE AND PRICE PERFORMANCE TRENDS
    • GENERICS AND REIMBURSEMENT CHANGES AFFECTING MARKETS
      • Canada Blood Glucose Test Strip Spending
      • TABLE 28 CANADIAN TEST STRIP REIMBURSEMENT LIMITS
      • E.U. Countries Limits on Meters and Test Strips
  • OTHER FACTORS INFLUENCING DEMAND
    • SELECTED CLINICAL GUIDELINES
    • TABLE 29 MEDICARE GUIDELINES, THROUGH 2014
    • TABLE 30 UNITED HEALTHCARE CLINICAL GUIDELINES, 2014
    • TABLE 31 BLUE CROSS/BLUE SHIELD OF MISSISSIPPI CLINICAL GUIDELINES, 2014
    • TABLE 32 AETNA CLINICAL GUIDELINES, 2014
    • TABLE 33 CIGNA CLINICAL GUIDELINES, 2014
  • CONTINUOUS GLUCOSE MONITORING IN PRIVATE PRACTICE AND HOSPITAL USE

CHAPTER 6 TECHNOLOGICAL INNOVATIONS, PIPELINE AND PATENT EVALUATION

  • INNOVATIVE BREAKTHROUGHS
    • BIONIC PANCREAS
    • GOOGLE'S SMART CONTACT LENS
    • MEDTRONIC'S MINIMED 530G WITH ENLITE TESTED AS AN OVERNIGHT CLOSED-LOOP SYSTEM
    • FLASH GLUCOSE MONITORING SYSTEM
    • INSULIN PATCH PUMPS
    • ROCHE ACCU-CHECK COMBO INSULIN INTERACTIVE PUMP
    • BECTON, DICKINSON AND JUVENILE DIABETES RESEARCH FOUNDATION COMBINATION DEVICE
    • U.K. RESEARCHERS AND THE ARTIFICIAL PANCREAS
    • TABLE 34 NEWLY ISSUED PATENTS AND PATENT APPLICATIONS, THROUGH 2014

CHAPTER 7 SELECTED CLINICAL TRIALS

  • NICE-SUGAR CLINICAL TRIAL
  • MEDTRONIC'S IN-CLINIC FEASIBILITY STUDY TO OBSERVE THE OVERNIGHT CLOSED-LOOP SYSTEM
  • AUTOMATED CLOSED-LOOP IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES
  • GLUCOSE CONTROL IN THE INTENSIVE CARE UNIT USING CONTINUOUS GLUCOSE MONITORING
  • PRECISE: A PROSPECTIVE, MULTI-CENTER EVALUATION OF THE ACCURACY OF A NOVEL CONTINUOUS IMPLANTED GLUCOSE SENSOR

CHAPTER 8 COMPANY PROFILES

  • ABBOTT DIABETES CARE INC.
  • ANIMAS CORP.
  • ARKRAY INC.
    • ARKRAY AMERICA INC.
  • BAYER HEALTHCARE AG
    • BAYER CORP.
  • BECTON, DICKINSON AND COMPANY
  • BRAUN MELSUNGEN AG
    • B. BRAUN MEDICAL INC.
  • CEQUR SA 8
    • CEQUR CORP.
  • DEBIOTECH SA
  • DEXCOM INC.
  • EDWARDS LIFESCIENCES
  • GLYSENS INC.
  • INSULET CORP.
  • JOHNSON & JOHNSON
    • MEDICAL DEVICES & DIAGNOSTICS
    • LIFESCAN
    • ANIMAS CORP.
  • LABSTYLE INNOVATIONS CORP.
  • MEDTRONIC INC.
    • MEDTRONIC DIABETES 9
  • MENARINI GROUP
  • ROCHE DIAGNOSTICS CORP.
  • SANOFI U.S.
  • SENSEONICS
  • TANDEM DIABETES CARE
  • VALERITAS

CHAPTER 9 APPENDIX

  • TABLE 35 GLOBAL CONTINUOUS GLUCOSE MONITORING MARKET BY DISEASE TYPE, THROUGH 2019 ($ MILLIONS)
  • TABLE 36 U.S. CONTINUOUS GLUCOSE MONITORING MARKET BY DISEASE TYPE, THROUGH 2019 ($ MILLIONS)
  • TABLE 37 CANADA CONTINUOUS GLUCOSE MONITORING MARKET BY DISEASE TYPE, 2013-2019 ($ MILLIONS)
  • TABLE 38 EUROPEAN UNION CONTINUOUS GLUCOSE MONITORING MARKET BY DISEASE TYPE, THROUGH 2019 ($ MILLIONS)
  • TABLE 39 ASIA CONTINUOUS GLUCOSE MONITORING MARKET BY DISEASE TYPE, THROUGH 2019 ($ MILLIONS)
  • TABLE 40 REST OF WORLD CONTINUOUS GLUCOSE MONITORING MARKET BY DISEASE TYPE, THROUGH 2019 ($ MILLIONS)
  • TABLE 41 GLOBAL CONTINUOUS GLUCOSE MONITORING MARKET BY AGE GROUP, 2013-2019 ($ MILLIONS)
  • TABLE 42 U.S. CONTINUOUS GLUCOSE MONITORING MARKET BY AGE GROUP, THROUGH 2019 ($ MILLIONS)
  • TABLE 43 CANADA CONTINUOUS GLUCOSE MONITORING MARKET BY AGE GROUP, THROUGH 2019 ($ MILLIONS)
  • TABLE 44 EUROPEAN UNION CONTINUOUS GLUCOSE MONITORING MARKET BY AGE GROUP THROUGH 2019 ($ MILLIONS)
  • TABLE 45 ASIA CONTINUOUS GLUCOSE MONITORING MARKET BY AGE, THROUGH 2019 ($ MILLIONS)
  • TABLE 46 REST OF WORLD CONTINUOUS GLUCOSE MONITORING MARKET BY AGE, THROUGH 2019 ($ MILLIONS)
  • TABLE 47 GLOBAL CONTINUOUS GLUCOSE MONITORING MARKET BY RACE, THROUGH 2019 ($ MILLIONS)
  • TABLE 48 GLOBAL HOME SETTING CONTINUOUS GLUCOSE MONITORING MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
  • TABLE 49 GLOBAL DIAGNOSTIC CENTER CONTINUOUS GLUCOSE MONITORING MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
  • TABLE 50 GLOBAL HOSPITAL CONTINUOUS GLUCOSE MONITORING MARKET BY REGION, THROUGH 2019 ($ MILLIONS)

LIST OF TABLES

  • SUMMARY TABLE 1 CONTINUOUS GLUCOSE MONITORING PRODUCT MARKET, THROUGH 2019 ($ MILLIONS)
  • SUMMARY TABLE 2 BLOOD GLUCOSE METER AND DIABETES TEST STRIP MARKETS, THROUGH 2019 ($ MILLIONS)
  • TABLE 1 GLOBAL AND REGIONAL DIABETES PREVALENCE, 2013 AND 2035 (MILLIONS)
  • TABLE 2 TOP 10 COUNTRIES WITH RESPECT TO DIABETIC POPULATIONS, 2013 AND 2035 (MILLIONS)
  • TABLE 3 INTERNATIONAL BLOOD LANCET SUPPLIERS
  • TABLE 4 AVAILABLE FEATURES WITHIN CONTINUOUS GLUCOSE MONITORING SYSTEMS, SEPTEMBER 2014
  • TABLE 5 COMPANIES IN THE TRANSMITTER AND RECEIVER MARKET, 2014 ($ MILLIONS, %)
  • TABLE 6 COMPANIES IN THE GLUCOSE SENSORS USED IN CONTINUOUS GLUCOSE MONITORING MARKET, 2014 ($ MILLIONS, %)
  • TABLE 7 COMPANIES IN THE INSULIN PUMPS USED IN CONTINUOUS GLUCOSE MONITORING MARKET, 2014 ($ MILLIONS, %)
  • TABLE 8 COMPANIES IN THE SELF-MONITORING OF BLOOD GLUCOSE METER MARKET, 2014 ($ MILLIONS, %)
  • TABLE 9 COMPANIES IN THE SELF-MONITORING OF BLOOD GLUCOSE TEST STRIP MARKET, 2014 ($ MILLIONS, %)
  • TABLE 10 GLOBAL CONTINUOUS GLUCOSE MONITORING PRODUCT MARKET SUMMARY, THROUGH 2019 ($ MILLIONS)
  • TABLE 11 U.S. CONTINUOUS GLUCOSE MONITORING AND RELATED PRODUCT MARKET, THROUGH 2019 ($ MILLIONS)
  • TABLE 12 CANADA CONTINUOUS GLUCOSE MONITORING PRODUCT MARKET, THROUGH 2019 ($ MILLIONS)
  • TABLE 13 EU CONTINUOUS GLUCOSE MONITORING PRODUCT MARKET, THROUGH 2019 ($ MILLIONS)
  • TABLE 14 ASIA CONTINUOUS GLUCOSE MONITORING PRODUCT MARKET, THROUGH 2019 ($ MILLIONS)
  • TABLE 15 REST OF WORLD CONTINUOUS GLUCOSE MONITORING PRODUCT MARKET, THROUGH 2019 ($ MILLIONS)
  • TABLE 16 GLOBAL TRANSMITTER AND RECEIVER MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
  • TABLE 17 GLOBAL GLUCOSE SENSOR MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
  • TABLE 18 GLOBAL INSULIN PUMP MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
  • TABLE 19 GLOBAL SELF-MONITORING OF BLOOD GLUCOSE METER AND TEST STRIP MARKET SUMMARY, THROUGH 2019 ($ MILLIONS)
  • TABLE 20 GLOBAL SELF-MONITORING OF BLOOD GLUCOSE METER AND TEST STRIP MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
  • TABLE 21 GLOBAL SELF-MONITORING OF BLOOD GLUCOSE METER MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
  • TABLE 22 GLOBAL TEST STRIP MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
  • TABLE 23 U.S. SELF-MONITORING OF BLOOD GLUCOSE METER AND TEST STRIP MARKET, THROUGH 2019 ($ MILLIONS)
  • TABLE 24 CANADA SELF-MONITORING OF BLOOD GLUCOSE METER AND TEST STRIP MARKET, THROUGH 2019 ($ MILLIONS)
  • TABLE 25 E.U. SELF-MONITORING OF BLOOD GLUCOSE METER AND TEST STRIP MARKET, THROUGH 2019 ($ MILLIONS)
  • TABLE 26 ASIA SELF-MONITORING OF BLOOD GLUCOSE METER AND TEST STRIP MARKET, THROUGH 2019 ($ MILLIONS)
  • TABLE 27 REST OF WORLD SELF-MONITORING OF BLOOD GLUCOSE METER AND TEST STRIP MARKET, THROUGH 2019 ($ MILLIONS)
  • TABLE 28 CANADIAN TEST STRIP REIMBURSEMENT LIMITS
  • TABLE 29 MEDICARE GUIDELINES, THROUGH 2014
  • TABLE 30 UNITED HEALTHCARE CLINICAL GUIDELINES, 2014
  • TABLE 31 BLUE CROSS/BLUE SHIELD OF MISSISSIPPI CLINICAL GUIDELINES, 2014
  • TABLE 32 AETNA CLINICAL GUIDELINES, 2014 5
  • TABLE 33 CIGNA CLINICAL GUIDELINES, 2014
  • TABLE 34 NEWLY ISSUED PATENTS AND PATENT APPLICATIONS, THROUGH 2014
  • TABLE 35 GLOBAL CONTINUOUS GLUCOSE MONITORING MARKET BY DISEASE TYPE, THROUGH 2019 ($ MILLIONS)
  • TABLE 36 U.S. CONTINUOUS GLUCOSE MONITORING MARKET BY DISEASE TYPE, THROUGH 2019 ($ MILLIONS)
  • TABLE 37 CANADA CONTINUOUS GLUCOSE MONITORING MARKET BY DISEASE TYPE, 2013-2019 ($ MILLIONS)
  • TABLE 38 EUROPEAN UNION CONTINUOUS GLUCOSE MONITORING MARKET BY DISEASE TYPE, THROUGH 2019 ($ MILLIONS)
  • TABLE 39 ASIA CONTINUOUS GLUCOSE MONITORING MARKET BY DISEASE TYPE, THROUGH 2019 ($ MILLIONS)
  • TABLE 40 REST OF WORLD CONTINUOUS GLUCOSE MONITORING MARKET BY DISEASE TYPE, THROUGH 2019 ($ MILLIONS)
  • TABLE 41 GLOBAL CONTINUOUS GLUCOSE MONITORING MARKET BY AGE GROUP, 2013-2019 ($ MILLIONS)
  • TABLE 42 U.S. CONTINUOUS GLUCOSE MONITORING MARKET BY AGE GROUP, THROUGH 2019 ($ MILLIONS)
  • TABLE 43 CANADA CONTINUOUS GLUCOSE MONITORING MARKET BY AGE GROUP, THROUGH 2019 ($ MILLIONS)
  • TABLE 44 EUROPEAN UNION CONTINUOUS GLUCOSE MONITORING MARKET BY AGE GROUP THROUGH 2019 ($ MILLIONS)
  • TABLE 45 ASIA CONTINUOUS GLUCOSE MONITORING MARKET BY AGE, THROUGH 2019 ($ MILLIONS)
  • TABLE 46 REST OF WORLD CONTINUOUS GLUCOSE MONITORING MARKET BY AGE, THROUGH 2019 ($ MILLIONS)
  • TABLE 47 GLOBAL CONTINUOUS GLUCOSE MONITORING MARKET BY RACE, THROUGH 2019 ($ MILLIONS)
  • TABLE 48 GLOBAL HOME SETTING CONTINUOUS GLUCOSE MONITORING MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
  • TABLE 49 GLOBAL DIAGNOSTIC CENTER CONTINUOUS GLUCOSE MONITORING MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
  • TABLE 50 GLOBAL HOSPITAL CONTINUOUS GLUCOSE MONITORING MARKET BY REGION, THROUGH 2019 ($ MILLIONS)

LIST OF FIGURES

  • SUMMARY FIGURE 1 GLOBAL CONTINUOUS GLUCOSE MONITOR PRODUCT MARKET, 2013-2019 ($ MILLIONS)
  • SUMMARY FIGURE 2 GLOBAL BLOOD GLUCOSE METER AND DIABETES TEST STRIP MARKETS, 2013-2019 ($ MILLIONS)
  • FIGURE 1 JUVENILE DIABETES RESEARCH FOUNDATION ARTIFICIAL PANCREAS PROJECT PLAN
  • FIGURE 2 COMPANIES IN THE TRANSMITTER AND RECEIVER MARKET, 2014 (%)
  • FIGURE 3 COMPANIES IN THE GLUCOSE SENSOR MARKET, 2014 (%)
  • FIGURE 4 COMPANIES IN THE INSULIN PUMPS USED IN CONTINUOUS GLUCOSE MONITORING MARKET, 2014 (%)
  • FIGURE 5 COMPANIES IN THE SELF-MONITORING OF BLOOD GLUCOSE METER MARKET, 2014
  • FIGURE 6 COMPANIES IN SELF-MONITORING OF BLOOD GLUCOSE TEST STRIP MARKET, 2014
  • FIGURE 7 CONTINUOUS GLUCOSE MONITORING PRODUCT MARKETS, 2013-2019 ($ MILLIONS)
  • FIGURE 8 CONTINUOUS GLUCOSE MONITORING PRODUCT MARKETS BY REGION, 2013-2019 ($ MILLIONS)
  • FIGURE 9 GLOBAL SELF-MONITORING OF BLOOD GLUCOSE METER AND TEST STRIP MARKET, 2013-2019
  • FIGURE 10 GLOBAL SELF-MONITORING OF BLOOD GLUCOSE METER AND TEST STRIP MARKET BY REGION, 2013-2019 ($ MILLIONS)
Back to Top